Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dissolution Testing Based On Scientific Justification Recommended By GPhA, PhRMA

This article was originally published in The Pink Sheet Daily

Executive Summary

Proposals from both the generic and innovator trade groups will be discussed at the Oct. 25-26 meeting of FDA’s Advisory Committee for Pharmaceutical Science.

You may also be interested in...



Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says

Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says

Mail-Order Pharmacy Not Necessarily Cheaper To Health Plans, Ohio Finds

Health plans should account for the rise in utilization that occurs with use of mail-order pharmacy when deciding if mail order saves money, Ohio Public Employees Retirement System Director of Healthcare Scott Streator said at the recent Academy of Managed Care Pharmacy Educational Conference in Chicago

Pfizer Torcetrapib Filing To Start ‘Dialogue,’ Not Necessarily Standard Review

Pfizer views its planned filing for its investigational HDL/LDL cholesterol combination therapy torcetrapib/Lipitor as the initiation of a dialogue between the company and FDA, not necessarily the start of a standard review

Topics

UsernamePublicRestriction

Register

PS061146

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel